US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ALPS Medical Breakthroughs ETF

62.20

-1.5276-2.40%

Post-market: 62.12-0.0806-0.13%19:30 EDT

Volume:19.49K

Turnover:1.21M

Market Cap:225.48M

PE:- -

High:63.39

Open:63.10

Low:61.96

Close:63.73

52wk High:70.85

52wk Low:36.32

Shares:3.63M

Float Shares:3.63M

Volume Ratio:0.41

T/O Rate:0.54%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

CG Oncology Director Leonard Post Disposes of 1,000 Shares for $71,170

Ani Pharmaceuticals Announces Intent to Appeal Rulings in CG Oncology Matter

Why Healthcare Stocks Look Like a Haven in This Market

ANI Pharmaceuticals intends to appeal rulings in CG Oncology matter

ANI Pharma Plans Delaware Supreme Court Appeal in CG Oncology Dispute

CG Oncology Director James Mulay Disposes of Common Shares Worth $1.82 Million

Press Release: $hareholder Alert: the M&A Class Action Firm Launches Legal Inquiry for the Merger

CG Oncology (CGON) In Focus Following Early Trial Results And BLA Timing Questions On Value

Simply Wall St.

Insilico Medicine Surges Over 7% in Morning Trading on New AI Drug Discovery Partnership with CMS

Apogee Therapeutics CEO Michael Thomas Henderson Disposes of USD 2.67 Million in Common Shares

Analysts Offer Insights on Healthcare Companies: aTyr Pharma (ATYR) and CG Oncology, Inc. (CGON)

HANXBIO-B Forges Strategic Alliance to Pioneer AI-Enhanced Drug Discovery Framework

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/SBIO/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"SBIO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SBIO\",,,,,undefined,":{"symbol":"SBIO","market":"US","secType":"STK","nameCN":"ALPS Medical Breakthroughs ETF","latestPrice":62.2006,"timestamp":1789761600000,"preClose":63.7282,"halted":0,"volume":19490,"hourTrading":{"tag":"盘后","latestPrice":62.12,"preClose":62.2006,"latestTime":"19:30 EDT","volume":18,"amount":1107.3954,"timestamp":1789774205561,"change":-0.0806,"changeRate":-0.001296,"amplitude":0},"delay":0,"changeRate":-0.023970549929230697,"floatShares":3625000,"shares":3625000,"eps":0,"marketStatus":"Not Yet Opened","change":-1.5276,"latestTime":"09-18 16:00:00 EDT","open":63.1,"high":63.385,"low":61.96,"amount":1214539.54164,"amplitude":0.022361,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":63.7282,"sharesOutstanding":2675000,"nav":62.25,"aum":225655960.35,"bidAskSpread":0.002808,"postHourTrading":{"tag":"盘后","latestPrice":62.12,"preClose":62.2006,"latestTime":"19:30 EDT","volume":18,"amount":1107.3954,"timestamp":1789774205561,"change":-0.0806,"changeRate":-0.001296,"amplitude":0},"volumeRatio":0.4133107687792956,"impliedVol":0.2645,"impliedVolPercentile":0.8446},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SBIO\",,,,,undefined,":{"symbol":"SBIO","floatShares":3625000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.4133107687792956,"shares":3625000,"dividePrice":0,"high":63.385,"amplitude":0.022361,"preClose":63.7282,"low":61.96,"week52Low":36.32,"pbRate":"--","week52High":70.85,"institutionHeld":0,"latestPrice":62.2006,"eps":0,"divideRate":0,"volume":19490,"delay":0,"ttmEps":0,"open":63.1,"prevYearClose":51.22,"prevWeekClose":63.29,"prevMonthClose":66.82,"prevQuarterClose":64.65,"fiveDayClose":63.29,"twentyDayClose":68.56,"sixtyDayClose":60.843},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SBIO\",params:#limit:5,,,undefined,":[{"date":"2024-12-19","symbol":"SBIO","amount":1.17346,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-19","defaultRemindTime":1734618600000,"name":"ALPS Medical Breakthroughs ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-19","currency":"USD","dateTimestamp":1734584400000,"payDate":"2024-12-26"},{"date":"2023-12-21","symbol":"SBIO","amount":0.07106,"announcedDate":"2023-12-20","type":"dividend","market":"US","newRecordDate":"2023-12-22","defaultRemindTime":1703169000000,"name":"ALPS Medical Breakthroughs ETF","recordDate":"2023-12-27","payableDate":"2023-12-22","currency":"USD","dateTimestamp":1703134800000,"payDate":"2023-12-27"},{"market":"US","date":"2019-12-19","symbol":"SBIO","amount":0.01585,"name":"ALPS Medical Breakthroughs ETF","recordDate":"2019-12-27","payableDate":"2019-12-20","currency":"USD","type":"dividend","dateTimestamp":1576731600000},{"market":"US","date":"2018-12-20","symbol":"SBIO","amount":0.78406,"name":"ALPS Medical Breakthroughs ETF","recordDate":"2018-12-27","payableDate":"2018-12-21","currency":"USD","type":"dividend","dateTimestamp":1545282000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SBIO\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-20","recordDate":"2018-12-21","paymentDate":"2018-12-27","value":0.78406,"currency":"USD"},{"executeDate":"2019-12-19","recordDate":"2019-12-20","paymentDate":"2019-12-27","value":0.01585,"currency":"USD"},{"executeDate":"2023-12-21","recordDate":"2023-12-22","paymentDate":"2023-12-27","value":0.07106,"currency":"USD"},{"executeDate":"2024-12-19","recordDate":"2024-12-19","paymentDate":"2024-12-26","value":1.17346,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SBIO\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SBIO\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2652280730","title":"CG Oncology Director Leonard Post Disposes of 1,000 Shares for $71,170","url":"https://stock-news.laohu8.com/highlight/detail?id=2652280730","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652280730?lang=en_us&edition=fundamental","pubTime":"2026-07-18 04:15","pubTimestamp":1784319335,"startTime":"0","endTime":"0","summary":"CG Oncology director Leonard Post disposes of 1,000 shares for $71,170CG Oncology director Leonard E. Post sold 1,000 common shares on July 15 at USD 71.17, cutting his direct stake to zero.Post also ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nNDL9wLLGG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"CG Oncology Director Leonard Post Disposes of 1,000 Shares for $71,170","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SBIO","CGON","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652209194","title":"Ani Pharmaceuticals Announces Intent to Appeal Rulings in CG Oncology Matter","url":"https://stock-news.laohu8.com/highlight/detail?id=2652209194","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652209194?lang=en_us&edition=fundamental","pubTime":"2026-07-17 06:33","pubTimestamp":1784241232,"startTime":"0","endTime":"0","summary":"July 16 (Reuters) - ANI Pharmaceuticals Inc::*ANI PHARMACEUTICALS ANNOUNCES INTENT TO APPEAL RULINGS IN CG ONCOLOGY MATTER*ANI PHARMACEUTICALS - TRIAL COURT DENIES ANI PHARMACEUTICALS' MOTION FOR NEW ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nRSD9341tC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANIP","BK4007","LU0566484027.USD","BK4139","LU1559883803.SGD","CGON","SBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652342763","title":"Why Healthcare Stocks Look Like a Haven in This Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2652342763","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652342763?lang=en_us&edition=fundamental","pubTime":"2026-07-17 05:07","pubTimestamp":1784236020,"startTime":"0","endTime":"0","summary":"Healthcare has outperformed the market over the past three months, thanks to promising biopharma developments and improved sentiment on large insurers, particularly those that serve seniors in the Med","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0820561818.USD","IE00BSNM7G36.USD","BK4581","LU0545039389.USD","IE0009355771.USD","LU0882574055.USD","LU1548497426.USD","XBI","LU1074936037.SGD","LU0225283273.USD","LU1668664300.SGD","FHLC","LU0158827781.USD","LU1732799900.SGD","XLV","IE00BFTCPJ56.SGD","LU0057025933.USD","RXL","AGNG","LU1923622614.USD","MEDX","HCSG","FTXH","ABBV","IYH","JDOC","VHT","LU0198837287.USD","IYF","APGE","LU0267386448.USD","LU0965509283.SGD","LU0289961442.SGD","BK4137","LU1244550494.USD","BK4585","LABU","IAI","SG9999011175.SGD","LU1791710400.SGD","PPH","FTXO","IXJ","LU0114720955.EUR","LU0511384066.AUD","LU2456880835.USD","KBWB","SBIO","BK4516","PJP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652427187","title":"ANI Pharmaceuticals intends to appeal rulings in CG Oncology matter","url":"https://stock-news.laohu8.com/highlight/detail?id=2652427187","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652427187?lang=en_us&edition=fundamental","pubTime":"2026-07-17 04:40","pubTimestamp":1784234411,"startTime":"0","endTime":"0","summary":"ANI Pharmaceuticals (ANIP) announced that Judge Sheldon K. Rennie, on July 16, denied ANI’s post-trial motions for a new trial and judgment as a ma...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ani-pharmaceuticals-intends-to-appeal-rulings-in-cg-oncology-matter-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ani-pharmaceuticals-intends-to-appeal-rulings-in-cg-oncology-matter-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CGON","IE00B3QW5Z07.USD","BK4135","SBIO","LU0566484027.USD","IE00BGHQF748.EUR","ANIP","CG","BK4007","IE00B64PRP62.GBP","BK4139","LU1559883803.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652422960","title":"ANI Pharma Plans Delaware Supreme Court Appeal in CG Oncology Dispute","url":"https://stock-news.laohu8.com/highlight/detail?id=2652422960","media":"Reuters","labels":["shareholding","policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652422960?lang=en_us&edition=fundamental","pubTime":"2026-07-17 04:34","pubTimestamp":1784234069,"startTime":"0","endTime":"0","summary":"ANI Pharma plans Delaware Supreme Court appeal in CG Oncology disputeANI Pharmaceuticals will appeal to the Delaware Supreme Court after a trial judge denied its post-trial motions in a dispute with C","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nNDL9M2TVg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDF","SBIO","CGON","LU2210150020.SGD","SG9999014005.SGD","SG9999014021.USD","LU0566484027.USD","IE00BGHQF748.EUR","LU0314104364.USD","BK4139","IE00B3QW5Z07.USD","SG9999014013.SGD","IE00BKPKM429.USD","LU1559883803.SGD","BK4588","LU2210149790.SGD","BK4585","IE00B64PRP62.GBP","LU2095319765.USD","IE00BN0W2V16.EUR","ANIP","BK4007","IE00BN0W2W23.USD","BK4112","SG9999014039.USD","IE00BN0W2T93.GBP","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651948960","title":"CG Oncology Director James Mulay Disposes of Common Shares Worth $1.82 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2651948960","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651948960?lang=en_us&edition=fundamental","pubTime":"2026-07-15 04:15","pubTimestamp":1784060148,"startTime":"0","endTime":"0","summary":"CG Oncology director James Mulay disposes of common shares worth $1.82 millionCG Oncology director James Mulay exercised director stock options for 24,165 common shares at $26.63 on July 10, 2026.Mula","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nNDL6YPf6w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"CG Oncology Director James Mulay Disposes of Common Shares Worth $1.82 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SBIO","BK4139","CGON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651486763","title":"Press Release: $hareholder Alert: the M&A Class Action Firm Launches Legal Inquiry for the Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=2651486763","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651486763?lang=en_us&edition=fundamental","pubTime":"2026-07-15 04:00","pubTimestamp":1784059200,"startTime":"0","endTime":"0","summary":"NEW YORK, July 14, 2026 /PRNewswire/ --Class Action Attorney Juan Monteverde with Monteverde & Associates PC , has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating-- Corebridge Financial, Inc.   related to its merger with. Equitable Holdings, Inc. Upon closing of the proposed transaction,Corebridge shareholders will own approximately 51% of the combined. Brokerage Inc. Under the terms of the proposed transaction, RE/MAX. About Monteverde & Associates PCOur firm litigates and has recovered money for shareholders...and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court.No company, director or officer is above the law. If you own common stock in the above listed compan","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4504","LU1201861249.SGD","LU0072461881.USD","LU2236285917.USD","LU0130102774.USD","BK4079","FTXO","GBCS","BK4184","LU0053671581.USD","BK4585","LU2360032135.SGD","LU0170899867.USD","LU0128525689.USD","BK4225","BK4588","LU1244550577.SGD","SBIO","LU1244550221.USD","IYF","CRBG","CUL3","BK4207","LU0162691827.USD","LU0477156797.USD","LU2125154778.USD","LU0980610538.SGD","BK4139","LU0320765646.SGD","LU0203347892.USD","LU1506573853.SGD","LU1267930227.SGD","IE00B19Z3581.USD","LU1791807156.HKD","LU2456880835.USD","LU0130518102.USD","LU0130103400.USD","LU0106831901.USD","APGE","LU0130517989.USD","LU0098860793.USD","BK4566","LU1244550494.USD","LU0314106906.USD","PEVC","IE00BSNM7G36.USD","RMAX","LU2462157665.USD","BK4534","LU1162221912.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651281147","title":"CG Oncology (CGON) In Focus Following Early Trial Results And BLA Timing Questions On Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2651281147","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651281147?lang=en_us&edition=fundamental","pubTime":"2026-07-14 06:24","pubTimestamp":1783981455,"startTime":"0","endTime":"0","summary":"Early trial results and BLA timeline put CG Oncology in focus\nCG Oncology (CGON) is back in the spotlight after positive early Phase II data for cretostimogene grenadenorepvec with gemcitabine and clearer timing for a planned biologics license application in high-risk bladder cancer.\nSee our latest analysis for CG Oncology.\nThe recent early Phase II update and clearer BLA timeline appear to be feeding into sentiment around CG Oncology, with a 30-day share price return of 21.73% and a year to...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cgon/cg-oncology/news/cg-oncology-cgon-in-focus-following-early-trial-results-and","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cgon/cg-oncology/news/cg-oncology-cgon-in-focus-following-early-trial-results-and","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4135","DCF","IE00BGHQF748.EUR","CG","SBIO","CGON","BK4139","IE00B64PRP62.GBP","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156997423","title":"Insilico Medicine Surges Over 7% in Morning Trading on New AI Drug Discovery Partnership with CMS","url":"https://stock-news.laohu8.com/highlight/detail?id=1156997423","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156997423?lang=en_us&edition=fundamental","pubTime":"2026-07-13 10:10","pubTimestamp":1783908642,"startTime":"0","endTime":"0","summary":"Insilico Medicine (03696) shares rose more than 7% in early trading. At the time of writing, the stock is up 6.21% to HK$45.48, with a turnover of HK$332 million. On July 13th, according to a post on...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSKH","IE00BVYPNP33.GBP","IE00BMCWC346.EUR","IE00BGHQDM52.EUR","SG9999015978.USD","BK4588","ARTY","BBP","SBIO","00867","IE00BVYPNQ40.USD","LU2488822045.USD","AGIX","SG9999015952.SGD","SG9999015945.SGD","LFSC","GDOC","PBE","IE00BYV24P56.USD","AIPO","SG9999015986.USD","VTHR","WRND","BK1593","BK4585","SG9999004220.SGD","BK1191","QTOC","CHAT","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650640158","title":"Apogee Therapeutics CEO Michael Thomas Henderson Disposes of USD 2.67 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2650640158","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650640158?lang=en_us&edition=fundamental","pubTime":"2026-07-11 08:01","pubTimestamp":1783728072,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics CEO Michael Thomas Henderson disposes of USD 2.67 million in common sharesApogee Therapeutics CEO Michael Thomas Henderson cut his stake through a 20,000-share sale on July 8 at US","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260711:nNDL9480GQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Apogee Therapeutics CEO Michael Thomas Henderson Disposes of USD 2.67 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SBIO","BK4139","LU0053671581.USD","APGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650181447","title":"Analysts Offer Insights on Healthcare Companies: aTyr Pharma (ATYR) and CG Oncology, Inc. (CGON)","url":"https://stock-news.laohu8.com/highlight/detail?id=2650181447","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650181447?lang=en_us&edition=fundamental","pubTime":"2026-07-10 18:20","pubTimestamp":1783678834,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on aTyr Pharma (ATYR) and CG Oncology, Inc. (CGON) with...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-atyr-pharma-atyr-and-cg-oncology-inc-cgon-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-atyr-pharma-atyr-and-cg-oncology-inc-cgon-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","IE00B3QW5Z07.USD","CG","LABU","IE00B64PRP62.GBP","XLV","BK4581","BK4135","ATYR","BK4585","BK4137","HCSG","BK4139","BK4588","XBI","CGON","SBIO","LU0128526141.USD","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173871150","title":"HANXBIO-B Forges Strategic Alliance to Pioneer AI-Enhanced Drug Discovery Framework","url":"https://stock-news.laohu8.com/highlight/detail?id=1173871150","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173871150?lang=en_us&edition=fundamental","pubTime":"2026-07-07 19:12","pubTimestamp":1783422743,"startTime":"0","endTime":"0","summary":"HANXBIO-B has announced a strategic partnership aimed at harnessing the power of artificial intelligence to revolutionize the drug development process.The company has entered into a formal agreement...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFSC","QTOC","VTHR","GSKH","BK4588","BK1161","WRND","SBIO","03378","BK1173","ARTY","GDOC","IBB","AGIX","AIPO","BK1535","BBP","CHAT","BK4585","PBE"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":6,"totalSize":112,"code":"91000000","status":"200"}]}}